- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03779724
Isokinetic Exercises in Patients With Multiple Sclerosis
The Effects of Isokinetic Exercises on Muscle Strength, Joint Position Sense, and Kinesiophobia in Patients With Multiple Sclerosis: a Randomized Controlled Trial
Study Overview
Detailed Description
Objective: To evaluate the effects of isokinetic exercises on muscle strength, knee joint position sense, pain, kinesiophobia, and quality of life in patients with multiple sclerosis.
Design: Randomized controlled trial. Setting: Outpatient clinic. Participants: Fifty patients with multiple sclerosis. Interventions: Fifty patients who met the inclusion criteria were randomized to an isokinetic exercise (n:25) or home exercise programme (n:25). Sequentially numbered opaque envelopes were used for randomization.
Outcome measures: The outcome measures were the peak torque/body mass index of quadriceps and hamstring muscles at 60°/s and 180°/s velocities, the hamstring/quadriceps ratios at the same velocities, absolute angular errors of the 15°, 45°, and 60° and the mean absolute angular error of joint position sense of the less and more affected knees, and the scores of Multiple Sclerosis Quality of Life-54, Visual Analogue Scale, and Tampa Scale of Kinesiophobia.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Aksaray, Turkey
- Aksaray University Training and Research Hospital
-
Ankara, Turkey
- Ankara Training and Researc Hospital, Health Sciences University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- definite relapsing remitting MS and secondary progressive MS diagnosis
- mild and moderate MS determined by Kurtzke Expanded Disability Status Scale (EDSS) scores below 6.5
- a disease duration of more than one year.
Exclusion Criteria:
- having an acute exacerbation within the last three months
- intravenous pulse steroid therapy in the last four weeks
- grade 3-4 spasticity according to the Modified Ashworth Scale
- severe vision impairment
- severe fatigue and depression
- past knee surgery
- other neurologic diseases
- systemic diseases
- pregnancy
- having received an exercise program within the last four weeks.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: isokinetic exercise
The isokinetic dynamometer (Biodex Multijoint Pro 3) was used for isokinetic exercises.
The isokinetic exercise program was implemented over eight weeks, twice a week on non-consecutive days under the supervision of a doctor.
The number of repetitions undertaken by the patients over the program were as follows: first week 5 at 60°/s and 10 at 180°/s, second week 10 at 60°/s and 15 at 180°/s, third week 15 at 60°/s and 20 at 180°/s, fourth week 20 at 60°/s and 30 at 180°/s, and in the last four weeks 20 at 60°/s and 40 at 180°/s angular velocities.
Each block of 10 repetitions were performed as a set.
|
|
|
ACTIVE_COMPARATOR: home exercise
The patients undertook lower extremity strengthening and balance exercises three times a week for eight weeks without supervision.
They started with three repetitions, which was gradually increased to 10-15.
The patients were called two times a week to inquire about exercise continuity and encouraged to undertake the recommended exercises.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Isokinetic Muscle Strength Test of the More and Less Affected Knees
Time Frame: At baseline (10 minutes before the start of the treatment) and 8 weeks after start of the treatment
|
The peak torque/body mass index of the quadriceps and hamstring muscles at 60°/s and 180°/s velocities were measured by an isokinetic dynamometer (Biodex Multijoint Pro 3) in Newton/meter.
A definite muscle strength value has not been defined.
Literally, healthy controls and patients are compared.
Higher scores indicate better muscle strength.
|
At baseline (10 minutes before the start of the treatment) and 8 weeks after start of the treatment
|
|
Joint Position Sense of the More and Less Affected Knees
Time Frame: At baseline (10 minutes before the start of the treatment) and 8 weeks after start of the treatment
|
Absolute angular errors of the 15°, 45°, and 60° and the mean absolute angular error of the more and less affected knees were measured by an isokinetic dynamometer (Biodex Multijoint Pro 3) with active-active angular reproduction method.
Estimating the target angel procedure was repeated at 45°, 15°, and 60° and for both the more and less affected legs.
After the joint position sense testing, three angles estimated by the patients were averaged, and the angular error was calculated for each target angle.
Absolute angular error was calculated by averaging the angular errors, regardless of the numbers being negative or positive.
The absolute angular error values of the three target angles were averaged to obtain the mean absolute angular errors.
A definite angular error value has not been defined.
Literally, healthy controls and patients are compared.
Higher scores indicate worser joint position sense.
|
At baseline (10 minutes before the start of the treatment) and 8 weeks after start of the treatment
|
|
Tampa Scale of Kinesiophobia
Time Frame: At baseline (10 minutes before the start of the treatment) and 8 weeks after start of the treatment
|
Kinesiophobia which is described as fear of movement and physical activity was evaluated using the Tampa Scale of Kinesiophobia, which is a 17-item self-report survey.
The range of scores are from 17 to 68 where the higher scores indicate an increasing degree of kinesiophobia.
If the total score was above 37 points, the patient was considered to have a high level of kinesiophobia.
|
At baseline (10 minutes before the start of the treatment) and 8 weeks after start of the treatment
|
|
Multiple Sclerosis Quality of Life-54 Total Score, Physical and Emotional Composite Scores, and Pain Subscale Score
Time Frame: At baseline (10 minutes before the start of the treatment) and 8 weeks after start of the treatment
|
This is a multidimensional health-related quality of life measure that combines both generic and multiple sclerosis-specific symptoms in a single instrument.
The 54 items are divided into 12 multi-item and 2 single-item scales.Health distress, overall quality of life, emotional well-being, role limitations-emotional and cognitive funtion items' final scores averaged and mental composite score was calculated.
Physical function, health perceptions, energy/fatigue, role limitations-physical, pain, sexual function, social function, health distress items' final scores were averaged and physical composite score was obtained.Total score was obtained by averaging the mental and physical composite scores.Final scores can be between 0-100 points for total, mental, physical and pain scores.
Higher values indicate better quality of life for total, physical and mental scores and worser pain levels for pain score.
|
At baseline (10 minutes before the start of the treatment) and 8 weeks after start of the treatment
|
|
Visual Analog Scale
Time Frame: At baseline (10 minutes before the start of the treatment) and 8 weeks after start of the treatment
|
Pain intensity was evaluated with the Visual Analog Scale.
Using a ruler, a 10 cm line was drawn which provided a range of scores from 0-100.
Than the patients marked the point that showed their pain intensity on this line.
A higher score in Visual Analog Scale indicates greater pain intensity.
|
At baseline (10 minutes before the start of the treatment) and 8 weeks after start of the treatment
|
Collaborators and Investigators
Investigators
- Principal Investigator: Melek A Selçuk, MD, Aksaray University Training and Research Hospital
Publications and helpful links
General Publications
- Yahia A, Ghroubi S, Mhiri C, Elleuch MH. Relationship between muscular strength, gait and postural parameters in multiple sclerosis. Ann Phys Rehabil Med. 2011 May;54(3):144-55. doi: 10.1016/j.rehab.2011.02.004. Epub 2011 Mar 9. English, French.
- Robineau S, Nicolas B, Gallien P, Petrilli S, Durufle A, Edan G, Rochcongar P. [Eccentric isokinetic strengthening in hamstrings of patients with multiple sclerosis]. Ann Readapt Med Phys. 2005 Feb;48(1):29-33. doi: 10.1016/j.annrmp.2004.04.005. French.
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 5070
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Multiple Sclerosis
-
University Hospital, Basel, SwitzerlandSwiss National Science FoundationRecruitingMultiple Sclerosis (MS) | Relapsing-remitting Multiple Sclerosis (RRMS) | Secondary-progressive Multiple Sclerosis (SPMS) | Primary Progressive Multiple Sclerosis (PPMS)Switzerland
-
University of California, Los AngelesUnknownRelapsing-remitting Multiple Sclerosis | Secondary-progressive Multiple Sclerosis | Primary-progressive Multiple SclerosisUnited States
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Remittent ProgressiveJapan
-
Cabaletta BioNot yet recruitingProgressive Multiple Sclerosis | Multiple Sclerosis | Multiple Sclerosis (Relapsing Remitting) | Relapsing Multiple Sclerosis (RMS) | Progressive Multiple Sclerosis (PMS) | Multiple Sclerosis (MS) - Relapsing-remitting | Multiple Sclerosis - Relapsing Remitting
-
The Cleveland ClinicUniversity Hospitals Cleveland Medical CenterCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States
-
Icahn School of Medicine at Mount SinaiColumbia University; New York Stem Cell Foundation Research InstituteCompletedClinically Isolated Syndrome | Relapsing-Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Rigshospitalet, DenmarkOdense University Hospital; Aarhus University Hospital; Hvidovre University Hospital and other collaboratorsActive, not recruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisDenmark
-
Novartis PharmaceuticalsCompletedRelapsing-remitting Multiple Sclerosis | Active Secondary Progressive Multiple SclerosisJapan
-
Banc de Sang i TeixitsVall d'Hebron Research Institute (VHIR)CompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisSpain
-
BiogenElan PharmaceuticalsCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
Clinical Trials on exercises
-
Derya AzimCompletedStroke | Physiotherapy and RehabilitationTurkey
-
Gazi UniversityRecruitingScapular DyskinesisTurkey
-
Inonu UniversityBurcu TaluCompleted
-
Delta University for Science and TechnologyCompletedChronic Mechanical Low Back PainEgypt
-
Riphah International UniversityRecruitingPrimary DysmenorrheaPakistan
-
Firat UniversityRecruiting
-
Riphah International UniversityCompletedChronic Low Back Pain (CLBP)Pakistan
-
Riphah International UniversityRecruiting
-
Ertuğrul DemirdelAntalya Bilim UniversityEnrolling by invitationACL - Anterior Cruciate Ligament RuptureTurkey
-
National Institute of Rehabilitation, MexicoCompletedChronic Low Back Pain | Degenerative SpondylolisthesisMexico